Bottom line
Is DHS a good fund? The bottom line
DHS is a managed dividend & equity income ETF from WisdomTree.
Its expense ratio is 0.38% — about $38 a year on every $10,000 invested, cheaper than 85% of dividend & equity income funds we track.
It returned +12.9% over one year, +12.0% a year over five years, +9.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $1.5 billion in net assets and 326 holdings, its largest position is Abbvie Inc (4.9%) and the top 10 make up 32.3% of the portfolio.
What stands out
- Low cost: cheaper than 85% of dividend & equity income peers
- 5-year return beat 83% of category peers
- Broadly diversified (326 holdings)
Updated Nov 19, 2026
What DHS invests in
The WisdomTree U.S. High Dividend Fund (the Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree U.S. High Dividend Index (the Index).
The Fund employs a passive management or indexing investment approach designed to track the performance of the Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return, and other characteristics resemble the risk, return, and other characteristics of the Index as a whole. The Fund invests, under normal circumstances, at least 80% of its net assets, plus any borrowings for investment purposes, in constituents of the Index and/or investments that have economic characteristics that are substantially similar to the economic characteristics of such constituents. WisdomTree, Inc. (WisdomTree), the Index Provider and parent company of the Funds investment adviser, WisdomTree Asset Management, Inc. (WisdomTree Asset Management or the Adviser), designed…
From the fund's prospectus (filed Jul 29, 2026).
DHS performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| DHS | +12.9% | +12.0% | +9.6% |
| Dividend & Equity Income median | +14.6% | +10.1% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What DHS costs
On a $10,000 investment, DHS's 0.38% expense ratio costs about $38 a year. The prospectus estimates $480 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.
DHS top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Abbvie Inc ABBV | 4.94% |
| 2 | Merck & Company Inc MRK | 4.26% |
| 3 | Altria Group Inc MO | 3.79% |
| 4 | Texas Instruments Inc TXN | 3.42% |
| 5 | Exxonmobil Holdings Corp XOM | 3.16% |
| 6 | Philip Morris International Inc PM | 3.15% |
| 7 | At&t Inc T | 2.60% |
| 8 | Verizon Communications Inc VZ | 2.45% |
| 9 | Bristol-myers Squibb Company BMY | 2.31% |
| 10 | Chevron Corp CVX | 2.20% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 32.3% of the fund. See all top 25 holdings and asset mix →